엔케이젠바이오텍코리아

182400KOSDAQSector: Pharma & Biotech

₩3,670 0.00%Market cap ₩265.5BAs of Jul 21, 2026 close · updated once daily

Grade D32.1 ptsTop 83% of 2,523 stocks

Financial strength

30.4

Growth momentum

47.4

Price attractiveness

23.0

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

30.4

How much debt does it carry relative to equity?

Debt-to-equity ratio

101.5%

✗ Below median · Top 75.8% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

210.4%

✓ Above median · Top 45.3% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-32.2%

✗ Below median · Top 64% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-140.9%

✗ Below median · Top 93.3% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

47.4

How much did revenue grow in a year?

Revenue growth (YoY)

-10.7%

✗ Below median · Top 81.5% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

-11.3%

✗ Below median · Top 84.9% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

37.7%

✓ Above median · Top 24.8% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

94.9%

✓ Above median · Top 19.1% in sector

Sector median 3.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

23.0

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 58.7% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

37.45x

✗ Below median · Top 95.3% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15